Cite
HARVARD Citation
Berger, S. et al. (2019). Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. American journal of transplantation. 19 (11), pp. 3018-3034. [Online].